Ingredion Incorporated has announced a recommended all-cash offer to acquire Tate & Lyle PLC (Tate & Lyle) in a transaction that values the United Kingdom-headquartered ingredients group at an enterprise value of approximately £3.7 billion ($5.0 billion).
The transaction represents a highly complementary consolidation of two major players in the global food and beverage ingredients sector. By combining Ingredion’s extensive texture and sugar reduction platforms with Tate & Lyle’s global expertise in mouthfeel, sweetening, and dietary fortification, the combined entity aims to establish a scaled, next-generation food solutions provider capable of meeting growing consumer demand for clean-label, healthier, and cost-effective formulations.
Key Transaction Highlights
💰 Capital Valuation: Under the terms of the transaction, Tate & Lyle shareholders will receive 595 pence per share in cash, representing an approximate 59% premium to the closing share price on 13 May 2026.
📈 Targeted Synergies: The combined business expects to achieve annual run-rate net cost synergies of approximately $130 million by the end of 2030, with the transaction expected to be adjusted EPS accretive in the first year post-completion.
🧪 Complementary Portfolios: Unifies Ingredion’s starch and texturant lines with Tate & Lyle’s proprietary sweetening, mouthfeel, and soluble fibre portfolios.
🌍 Global Footprint Expansion: Integrates supply networks and distribution chains across North America, Europe, the Middle East, Africa, and the Asia Pacific region.
Transaction Structure and Shareholder Premiums
The recommended all-cash offer of 595 pence per share allows Tate & Lyle shareholders to crystallise their investment at a significant premium. Additionally, eligible shareholders will remain entitled to receive a final dividend of up to 13.2 pence per share for the financial year ending 31 March 2026, as well as an interim dividend of up to 6.8 pence per share for the six-month period ending 30 September 2026.
Ingredion plans to finance the acquisition through a combination of existing cash reserves, new debt financing, and a fully committed bridge financing facility. At completion, pro forma net leverage is projected to be approximately 3.0x net debt-to-adjusted EBITDA. Ingredion has stated its commitment to retaining its investment-grade credit profile, with plans to deleverage the balance sheet to approximately 2.5x within 18 months following the transaction close.
The acquisition is structured to be implemented via a court-sanctioned scheme of arrangement under Part 26 of the United Kingdom Companies Act 2006, though Ingredion reserves the right to proceed via a takeover offer if necessary, subject to the consent of the UK Panel on Takeovers and Mergers.
Core Strategic Pillars and Industrial Synergy
The business consolidation addresses several long-term structural trends in the global food, beverage, and industrial ingredients markets.
Speciality Ingredients Scaling
The combination expands Ingredion’s texturant, sugar reduction, and fortification platforms. Integrating Tate & Lyle's established mouthfeel systems allows the combined group to offer multi-ingredient systems and comprehensive recipe development capabilities to multinational food brands.
Customer Centric Innovation and Formulation
By pooling intellectual property, application suites, and technical personnel, the combined group aims to accelerate speed-to-market. Joint applications laboratories will develop bespoke ingredient systems from initial concept through to commercialisation, optimising costs for mid-tier and enterprise customers.
Supply Chain and Logistical Optimisation
The transaction bridges geographical gaps, blending Ingredion's strong footprint in the Americas with Tate & Lyle’s deep-seated relationships and operations in Europe and emerging markets. This integrated network is designed to mitigate supply chain disruptions and lower shipping overheads.
Jim Zallie, Chairman, President, and CEO of Ingredion, commented on the industrial logic of the transaction:
"Combining Ingredion and Tate & Lyle’s complementary portfolios establishes a global leader in ingredient solutions with the innovation expertise and geographic reach that will help create the future of food. The combined business will be better positioned to serve customers’ needs for the development of great-tasting, healthier, and affordable food products that consumers demand."
David Hearn, Chair of Tate & Lyle, expressed support for the valuation and stewardship of the business:
"Over the last few years, Tate & Lyle has been successfully repositioned as a leading global speciality food and beverage solutions business aligned to growing consumer demand for healthier, more nutritious, and sustainable food and drink. Looking forward, we believe the next chapter with Ingredion will create a business with even greater potential, greater scale, and increased investment in innovation. The Board therefore unanimously recommends Ingredion's offer to Tate & Lyle’s shareholders."
Regulatory Clearances and Corporate Advisors
The transaction has been unanimously approved by Ingredion's Board of Directors. The Board of Tate & Lyle similarly intends to recommend unanimously that its shareholders vote in favour of the scheme of arrangement at the upcoming court-convened meeting and general meeting.
To secure structural support, Ingredion has already received an irrevocable undertaking from Huber Equity Corporation to vote in favour of the scheme. This undertaking represents 75,000,000 ordinary shares, or approximately 16.8% of Tate & Lyle’s issued ordinary share capital as of 5 June 2026.
Pending customary closing conditions, antitrust reviews, and the formal sanction of the High Court of Justice in England and Wales, the transaction is expected to close in the second half of 2027.
Professional Advisory Lineup
The corporate transaction is being guided by several prominent investment banking and legal firms:
For Ingredion: J.P. Morgan Securities LLC is serving as sole financial advisor, with Hogan Lovells (comprising Hogan Lovells International LLP and Hogan Lovells US LLP) acting as legal counsel.
For Tate and Lyle: Goldman Sachs International and Greenhill & Co. International are serving as joint lead financial advisors. Bank of America and Citi are acting as joint financial advisors and corporate brokers. Linklaters LLP is serving as legal counsel.
.jpg)
